Introduction {#s01}
============

Protein quality control is essential for cellular function and viability ([@bib16]; [@bib66]; [@bib86]). The capacity of the quality control systems can be exceeded under certain conditions, resulting in the accumulation of misfolded proteins ([@bib7]; [@bib25]). Protein misfolding and/or mislocalization are implicated in human neurodegenerative disease ([@bib67]; [@bib2]). In the amyloid diseases, the misfolded proteins associate into amyloid assemblies, formed by a self-templating β sheet--rich conformation ([@bib10]; [@bib20]). Prions, which occur in fungi and mammals, constitute a transmissible form of amyloid.

Cells have evolved diverse mechanisms to prevent and reverse protein misfolding and aggregation ([@bib66]; [@bib86]). In yeast, nonamyloid amorphous aggregates accumulate in various quality control compartments ([@bib30]; [@bib81]; [@bib23]; [@bib18]; [@bib45]). Deposits found in the nucleus (intranuclear quality control, previously described as juxtanuclear; [@bib30]) contain soluble, highly mobile, and ubiquitinated proteins that are likely destined for proteasomal degradation ([@bib44]). In contrast, other aggregates, such as prions, which may be more resistant to disaggregation and proteolysis, are sequestered into relatively immobile compartments for terminally aggregated proteins such as the insoluble protein deposit ([@bib30]). Many of the cellular factors that target the different aggregates to these functionally distinct compartments are known ([@bib66]).

Yeast prions provide a favorable model for assessing amyloid formation and its interactions with the cellular quality control network ([@bib40]). Yeast possess many prion proteins, although perhaps the best characterized is that of the prion form of Sup35, \[*PSI*+\] ([@bib41]; [@bib59]; [@bib72]; [@bib15]). Sup35 consists of a C-terminal translation termination factor GTPase domain after the prion-determining N-terminal (N) and middle (M) domains. The N domain, essential for \[*PSI*+\] induction and propagation, is rich in glutamine and asparagine (Q/N) residues and constitutes the minimal prion/fibril-forming region ([@bib22]; [@bib34]; [@bib52]; [@bib9]). The function of the charged M domain is unknown, although it may mediate an interaction with the heat shock protein Hsp104 disaggregase, a protein remodeling factor essential for yeast prion propagation ([@bib27]). Fibril assembly by the prion-forming domain sequesters soluble Sup35 into insoluble amyloid aggregates, impairing efficient cellular translation termination ([@bib40]).

The key molecular chaperones involved in processing and propagation of yeast prions are Hsp70 and its cofactors Hsp40, Hsp104, and Hsp110/Sse1 ([@bib40]; [@bib74]; [@bib84]; [@bib14]; [@bib66]). Although the small heat shock proteins Hsp42 and Hsp26 can influence de novo \[*PSI*+\] prionogenesis ([@bib17]), it is the Hsp70/Hsp40 system that is believed to target the prion fragmentation machinery in yeast. Growing evidence suggests that Hsp70s such as Ssa1 or Ssa2, together with Sis1 (Hsp40), initially bind prion aggregates and recruit Hsp104 for remodeling of the prion aggregates ([@bib46]; [@bib28]; [@bib69]; [@bib31]). Sse1 (Hsp110), a nucleotide exchange factor for Hsp70, regulates de novo \[*PSI*+\] induction and functions in prion propagation by modulating the nucleotide occupancy of Hsp70 ([@bib19]; [@bib36]; [@bib55]). In addition, Sse1 may promote prion nucleation as well as interact directly with prion aggregates ([@bib6]; [@bib55]).

Mammals lack an Hsp104 homologue, but they have a disaggregase system composed of Hsp70, Hsp40, and Hsp110 ([@bib63]; [@bib53]). Furthermore, mammalian Hsp110 has been shown to reverse the toxicity associated with mutant superoxide dismutase 1 aggregation in an axonal transport model ([@bib65]).

For yeast prions, the balance between fibril self-assembly, growth, and chaperone-mediated fragmentation/disassembly determines the outcome of prion propagation in vivo. We therefore sought to determine the spatial relationship between Hsp70-related molecular chaperones and prion aggregates in a \[*PSI*+\] model. We used a well-characterized overexpression system consisting of a fusion of the Sup35 NM domain to YFP (NM-YFP) to amplify the prion aggregate structure in our strains ([@bib74]). This allowed us to use correlative light and cryoelectron microscopy to probe the conformation of NM-YFP prion aggregates in vivo. We used these organized \[*PSI*+\] deposits ([@bib33]; [@bib75]; [@bib56]) to investigate the cellular determinants of prion assembly and processing in yeast. Using individual chaperone deletions, we modulated the balance between assembly and disassembly of NM-YFP dot aggregates and revealed a novel, nonfibrillar form of prion aggregate. This work demonstrates a key role for Sse1 (Hsp110), in cooperation with Hsp104, in regulating the length and assembly state of \[*PSI*+\] prion fibrils in vivo.

Results {#s02}
=======

Correlative microscopy and electron tomography of a \[*PSI+*\] prion model {#s03}
--------------------------------------------------------------------------

We exploited the well-characterized yeast \[*PSI*+\] prion expression model, NM-YFP, to visualize aggregates of \[*PSI+*\] in vivo. This was constitutively overexpressed in cells lacking the endogenous NM region of *SUP35* ([@bib75]; [@bib56]), so that NM-YFP aggregates were propagated while leaving the endogenous Sup35p C-terminal translation termination domain free from toxic recruitment into the prion ([@bib11], [@bib12]; [@bib78]). The NM-YFP aggregates in our model system assembled into one large focus or "dot" structure ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp1}, top). To study the 3D structural organization of these dot aggregate species in cells, we used a combination of high-pressure freezing, freeze substitution, resin embedding, and ultramicrotomy to generate well-preserved stained sections for electron tomography. In parallel, we used cryoelectron tomography of unstained vitrified cell sections to confirm that the observed structures reflect the true assemblies in their native hydrated state ([@bib3][@bib4]). In both instances, the YFP fluorescence was maintained by the preparation procedures, enabling direct correlation with EM of the aggregates (Materials and methods). The NM-YFP dot aggregates formed ordered fibrillar arrays ([Fig. 1 A](#fig1){ref-type="fig"} and Fig. S1, B--E), in agreement with previous studies ([@bib33]; [@bib75]; [@bib9]; [@bib56]).

![**Aggregate remodeling in chaperone knockout strains.** Representative tomographic slices through reconstructions of NM-YFP dots in HM20-embedded cell sections from cells with a wild-type chaperone complement and those with Δ*ssa1*, Δ*ssa2*, and Δ*sse1* deletions, as indicated. Fibril-containing regions are outlined in yellow, unstructured perimeter zones are outlined in red, and dark amorphous aggregates are outlined in blue. These structures were visible in 100% of the aggregates of each respective strain and were from at least 20 independent NM-YFP dot observations (tomograms and projections). Bars, 200 nm. (A) Wild-type chaperone complement. The yellow outline around the fibril aggregate was manually traced by following the interface between the fibrils and the cytosolic ribosomes. (B) Δ*ssa1*. The yellow outline around the fibrils was manually traced at the interface between the fibrils and the unstructured peripheral layer. The red outline was traced at the interface between the unstructured zone and the cytosolic ribosomes. The blue outline was drawn around the perimeter of the dark amorphous material. (C) Δ*ssa2*. The red, yellow, and blue outlines were defined as in B. (D) Δsse*1.* The yellow outline was defined as in A and the blue outline was defined as in B. (E) Distribution plots of individual fibril lengths in tomograms of NM-YFP aggregates from wild-type, Δ*ssa1*, Δ*ssa2*, and Δ*sse1* cells. Fibrils were measured in at least three independent dot assemblies for each strain. The total number of fibrils was 450 for the wild type, 171 for Δ*ssa1*, 668 for Δ*ssa2*, and 407 for the Δ*sse1* aggregates. For each histogram, the number of bins was equal to the square root of the number of elements in the data set. A Weibull distribution was calculated for the data and plotted with each histogram.](JCB_201505104_Fig1){#fig1}

Deletion of individual molecular chaperones causes aggregate remodeling {#s04}
-----------------------------------------------------------------------

Transient inactivation of Hsp70 chaperones can influence the organization of \[*PSI*+\] assemblies ([@bib56]) and their association with chaperones ([@bib85]). To systematically probe the chaperone actions, we constructed single Hsp70 (Δ*ssa1* and Δ*ssa2*) or Hsp110/Sse1 (Δ*sse1*) chaperone knockouts of our \[*PSI*+\] prion model strain (Materials and methods), and we assessed the resulting alterations to the aggregate structures in these cells by correlative fluorescence and electron tomography. There was no obvious alteration in the fluorescence pattern of NM-YFP aggregates in any of the single chaperone deletion strains compared with cells with a wild-type chaperone complement (Fig. S1 A). However, electron tomography of the deletion strains showed striking deviations from the normal dot arrangement ([Fig. 1, A--D](#fig1){ref-type="fig"}; and [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp2}, A--E). The deletions introduced in both Δ*ssa1* or Δ*ssa2* strains resulted in the appearance of featureless perimeter zones surrounding the fibrillar core of the aggregate ([Fig. 1, B and C](#fig1){ref-type="fig"}; and Fig. S2, A and C). Occasionally, the dot aggregates entirely consisted of this nonfibrillar zone (Fig. S2 B), although this could be a result of the section plane not passing through the center of the dot. Where present, the fibrils in the core region were similar in length to NM-YFP fibrils formed with a wild-type chaperone background ([Fig. 1 E](#fig1){ref-type="fig"}, wild type, Δ*ssa1*, and Δ*ssa2*) and had a normal packing arrangement ([Fig. 1, A--C](#fig1){ref-type="fig"}). In addition to the nonfibrillar perimeter shells, clumps of dark-staining amorphous material were often seen interspersed with the NM-YFP fibril assemblies in these two Hsp70 deletion strains. All of these features could be readily identified in cryotomograms of vitreous sections of these cells, precluding any significant artifact from our sample preparation method (Fig. S2, E and F).

The deletion of *SSE1* slowed the growth of our model strain, as reported elsewhere ([@bib49]; [@bib71]; [@bib1]). Here, we noted extensive areas of dark amorphous material intercalated with large but otherwise normal-looking dot fibril arrays ([Fig. 1 D](#fig1){ref-type="fig"} and Fig. S2 D). This amorphous material formed a coarse meshwork when present toward the center of the NM-YFP fibril assemblies ([Fig. 1 D](#fig1){ref-type="fig"} and Fig. S2 D). Although packing within these fibril arrays was similar to those in cells with a wild-type chaperone complement, the individual fibrils themselves were found to be approximately 60% longer ([Fig. 1 E](#fig1){ref-type="fig"}, wild type and Δ*sse1*).

These large structural modifications to the NM-YFP dot aggregates in each of the three chaperone deletions strains (Δ*ssa1*, Δ*ssa2*, and Δ*sse1*) did not affect the stability of prion propagation. We monitored the presence of the fluorescent dot aggregates in these strains in successive progeny (50 generations for Δ*ssa1* and Δ*ssa2*, and 32 generations for Δ*sse1*) and found them to persist just as stably as dots in cells with a wild-type chaperone complement ([@bib19]; [@bib36]; [@bib61]).

Similar to other insoluble protein deposit substrates ([@bib30]; [@bib32]; [@bib83]; [@bib87]), our overexpressed NM-YFP foci were immobile when analyzed by FRAP ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp4}). NM-YFP foci in each of the three individual chaperone deletion strains (Δ*ssa1*, Δ*ssa2*, and Δ*sse1*) displayed similar recovery curves (Fig. S3), regardless of whether the bleached region of interest was located in the center or more toward the periphery of the dot (not depicted). This indicated that despite the structural differences in these NM-YFP assemblies, the cells were still sequestering both the fibrillar and nonfibrillar aggregates into discrete foci with very little cytosolic exchange.

Chaperone deletion strains sustain a pool of small NM-YFP oligomers {#s05}
-------------------------------------------------------------------

The NM-YFP expression level in each of the individual chaperone deletion strains (Δ*ssa1*, Δ*ssa2*, and Δ*sse1*) was similar to that observed in cells with a wild-type complement of chaperones, whether NM-YFP was in the \[*PSI*+\] prion state or \[*psi*−\] soluble form ([Fig. 2 A](#fig2){ref-type="fig"}). Several lower molecular mass bands could also be seen in the blots. These bands were found to be specific to NM-YFP because an otherwise isogenic strain devoid of the NM-YFP cassette had no detectable signal on the Western blots ([Fig. 2 A](#fig2){ref-type="fig"}, control lane). These additional bands were likely attributable to proteolytic degradation; accordingly, soluble NM-YFP present in the \[*psi*−\] background appeared more susceptible to this phenomenon than the NM-YFP present in the amyloid form.

![**Chaperone deletion alters the size distribution of NM-YFP aggregates.**(A) Western blot of cell lysates using an α-YFP antibody showing NM-YFP expression levels in \[*PSI*+\], \[*psi*−\], Δ*ssa1*, Δ*ssa2*, and Δ*sse1* cells. The parental wild-type strain, devoid of the NM-YFP expression cassette, but otherwise isogenic, is included as a control. An α-Glucose-6-phosphate dehydrogenase (G6PD) antibody was used to verify equal loading of the lysates. (B) Ultracentrifugation sedimentation of NM-YFP aggregates in lysates of \[*PSI*+\], \[*psi*−\], Δ*ssa1*, Δ*ssa2*, and Δ*sse1* cells, analyzed by Western blot using an α-YFP antibody. Lysate (L), supernatant (S), and pellet (P) fractions are indicated. (C) SDD-AGE analysis and immunoblotting of the ultracentrifugation fractions described in B. (D) Slice through a representative cryotomogram of an NM-YFP dot aggregate isolated from the pellet fraction of the ultracentrifuged \[*PSI*+\] cell lysate. Of seven individual pelleted dots observed, 43% had preserved the fibril array architecture, as shown, whereas the remainder consisted of disordered clusters of NM-YFP fibrils. The disorder in fibril packing for these dots had been introduced by sample handling, because all dot assemblies from five independent dot aggregates observed directly in the lysates, without ultracentrifugation, had a well-preserved fibril array arrangement consistent with the example shown. Bar, 200 nm.](JCB_201505104_Fig2){#fig2}

The oligomeric properties of the NM-YFP aggregates in lysates from each of these strains were assessed by ultracentrifugation ([Fig. 2 B](#fig2){ref-type="fig"}). As expected for aggregates formed with a wild-type chaperone complement, a substantial part of the full-length NM-YFP was in the pellet fraction ([Fig. 2 B](#fig2){ref-type="fig"}, \[*PSI*+\]). We analyzed this fraction by correlative cryofluorescence/cryoelectron tomography and found that the normal fibrillar array organization was partly preserved for many of the dot aggregates ([Fig. 2 D](#fig2){ref-type="fig"}). For lysates from each of the Δ*ssa1*, Δ*ssa2*, and Δ*sse1* strains, the full-length NM-YFP population was clearly observed in both the supernatant and pellet fractions after ultracentrifugation ([Fig. 2 B](#fig2){ref-type="fig"}). These supernatant pools of NM-YFP were composed of a smaller oligomeric species, but not monomeric NM-YFP, as assessed by semidenaturating detergent agarose gel electrophoresis (SDD-AGE; [Fig. 2 C](#fig2){ref-type="fig"}). The presence of these small oligomeric aggregates coincides with the appearance of the amorphous material in dot assemblies in these mutant backgrounds as described earlier ([Fig. 1, B--D](#fig1){ref-type="fig"}).

Hsp104 is localized to the periphery of NM-YFP aggregates {#s06}
---------------------------------------------------------

To relate the observed structures to changes in chaperone levels, we monitored global Hsp104, Hsp70 (SSA), and Hsp110 (Sse1) expression levels in each of our single chaperone deletion strains. Global Hsp70 and Sse1 expression was not significantly altered in the deletion strains relative to their levels in cells with a wild-type complement of chaperones ([Fig. 3 A](#fig3){ref-type="fig"}). A weak Hsp110 signal was detectable in our Δ*SSE1* strain, which was likely attributable to Sse2 (which has 76% identity to Sse1), although Sse2 does not functionally substitute for Sse1 in \[*PSI*+\] prion biology ([@bib48]). In contrast, Hsp104 levels were significantly altered in the single chaperone deletions ([Fig. 3, A and B](#fig3){ref-type="fig"}). In the Hsp70 deletion backgrounds (Δ*ssa1* and Δ*ssa2*), Hsp104 levels increased three- to fivefold, whereas no statistically significant increase was observed in the Δ*sse1* strain. Therefore, it appears that Hsp104 is increased to compensate for the loss of a particular Hsp70 (Ssa1 or Ssa2), as described elsewhere ([@bib29]).

![**NM-YFP assemblies have a nonuniform distribution of molecular chaperones.**(A) Western blot of cell lysates showing Hsp104, Hsp70, and Sse1 expression levels in cells with a wild-type chaperone complement, which were either \[*PSI*+\] (NM-YFP aggregate dots) or \[*psi*−\] (soluble NM-YFP expressed but not converted to the prion state) and Δ*ssa1*, Δ*ssa2*, and Δ*sse1* cells. Glucose-6-phosphate dehydrogenase (G6PDH) was used as a loading control. (B) Plot of the quantitation of three independent immunoblots with the αHsp104 antibody, as indicated. The abundance of Hsp104 for each of the lysates is expressed relative to its level in the \[*PSI*+\] lysate and error bars correspond to the SD between the replicates. (C) Representative confocal Z-sections showing the distribution of mCherry-tagged Hsp104, Ssa1, Ssa2, and Sis1 on NM-YFP aggregates in cells with a wild-type complement of chaperones. The data are representative of at least 20 different NM-YFP dots for each labeled chaperone from two independent experiments. Imaging was optimized to visualize the fluorescence from the dot aggregates. A line plot illustrating the colocalization of Hsp104-mCherry with the NM-YFP dot is shown in [Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp5}. Bars, 2 µm. (D) Representative confocal Z-sections showing the distribution of mCherry-tagged Hsp104, Ssa1, and Sis1 on NM-YFP aggregates in Δ*ssa1* cells. Δ*ssa2* cells displayed a similar chaperone distribution and thus have been omitted here. The data are representative of at least 20 different NM-YFP dots for each labeled chaperone from two independent experiments. Imaging was optimized to visualize the fluorescence from the dot aggregates. A line plot illustrating the colocalization of Hsp104-mCherry with the NM-YFP dot in this strain is shown in Fig. S4 B. (E) Representative confocal Z-sections showing the distribution of mCherry-tagged Hsp104 and Hsp70 (Ssa1 and Ssa2) on NM-YFP aggregates in Δ*sse1* cells. We were unable to obtain a viable Sis1-tagged clone in this deletion strain. The data are representative of at least 20 different NM-YFP dots for each labeled chaperone from two independent experiments. Imaging was optimized to visualize the fluorescence from the dot aggregates. A line plot illustrating the colocalization of Hsp104-mCherry with the NM-YFP dots in this strain is shown in Fig. S4 C.](JCB_201505104_Fig3){#fig3}

Molecular chaperones are abundant in yeast prion aggregates ([@bib13]; [@bib5]; [@bib38]; [@bib6]; [@bib69]; [@bib75]; [@bib56]; [@bib87]). To assess the spatial distribution of molecular chaperones within the NM-YFP dot aggregates in our deletion strains, we created a series of mCherry fusions. C-terminally tagged Hsp104, Hsp70 (Ssa1 and Ssa2), and Hsp40 (Sis1) derivatives were constructed by integrating a copy of mCherry in frame with the endogenous coding regions. Confocal microscopy was then used to assess their respective cellular distributions. Hsp70 (Ssa1 and Ssa2) and Hsp40 (Sis1) were distributed evenly throughout NM-YFP dot aggregates in cells with a wild-type chaperone complement and in those with single Hsp70 deletions (Δ*ssa1* or Δ*ssa2*; [Fig. 3, C and D](#fig3){ref-type="fig"}). Although Hsp104 was also seen to colocalize with the NM-YFP dot assemblies in these cells, it was concentrated around the periphery of the dots ([Fig. 3, C and D](#fig3){ref-type="fig"}). Although the Hsp104-mCherry intensity was very weak in cells with a wild-type chaperone complement ([Fig. 3 C](#fig3){ref-type="fig"}), the peripheral signal was still slightly higher than the central area ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp6}). However, the strong Hsp104-mCherry fluorescence in the Hsp70 deletion strains (Δ*ssa1* and Δ*ssa2*) clearly showed its peripheral distribution ([Fig. 3 D](#fig3){ref-type="fig"} and Fig. S4 B). In the Δ*sse1* strain, Hsp104 was almost exclusively confined to the perimeter of the dots ([Fig. 3 E](#fig3){ref-type="fig"} and Fig. S4 C), with the mCherry signal toward the center at background level. Hsp70 (Ssa1 and Ssa2) also showed a preferred localization toward the periphery of NM-YFP dots in the Δ*sse1* strain ([Fig. 3 E](#fig3){ref-type="fig"}).

Amorphous shells surrounding NM-YFP fibrils are enriched in Hsp110 {#s07}
------------------------------------------------------------------

We used immunogold EM on freeze-substituted sections to define the chaperone distributions in NM-YFP dots on the nanoscale. An anti--YFP antibody clearly localized NM-YFP in all of the cell sections ([Fig. 4](#fig4){ref-type="fig"}). As in the confocal analysis, NM-YFP was confined to the dot assemblies with little or no cytosolic labeling ([Fig. 4](#fig4){ref-type="fig"}). In the Hsp70 deletions (Δ*ssa1* or Δ*ssa2*), NM-YFP was also detected in the nonfibrillar perimeter shells and the dark amorphous material of the dot aggregates ([Fig. 4 B](#fig4){ref-type="fig"}). However, the dark amorphous material observed in dot aggregates in the Δ*sse1* strain was sparsely labeled (if at all), suggesting either poor accessibility of the antibody or that this material is composed of other aggregates ([Fig. 4 C](#fig4){ref-type="fig"}).

![**Immunogold labeling of NM-YFP in dot assemblies in Hsp70 and Hsp110 knockout cell sections.** Representative EM projection images of immunogold-labeled cell sections of cells with a wild-type chaperone complement and those from Δ*ssa1* and Δ*sse1* cells, as indicated. Δ*ssa2* cell sections exhibited similar labeling as Δ*ssa1* and thus projections of these were omitted from the figure. An α-YFP antibody was used to detect and label the NM-YFP prion protein fusion and the images are representative of at least 10 independent NM-YFP dots observed in each strain. Bars, 0.5 µm. (A) Wild-type chaperone complement. Fibril-containing regions are outlined in yellow as described in [Fig. 1 A](#fig1){ref-type="fig"}. (B) Δ*ssa1*. Fibril-containing regions are outlined in yellow, unstructured perimeter zones are outlined in red, and dark amorphous aggregates are outlined in blue, as described in [Fig. 1 B](#fig1){ref-type="fig"}. (C) Δ*sse1*. Fibril-containing regions are outlined in yellow and dark amorphous aggregates are outlined in blue, as in A and B. (D) Graphs illustrate the labeling efficiency with this antibody on the NM-YFP dot aggregates or in the cytosol. The data are representative of at least five independent observations and the error bars correspond to the SD in the data. C, cytosol; D, dot aggregate; WT, wild type.](JCB_201505104_Fig4){#fig4}

Regarding the distribution of Hsp70 in cell sections, we noted a sixfold higher concentration in the dots compared with cytosolic levels of Hsp70 in strains with a wild-type chaperone complement and the Hsp70 deletions, Δ*ssa1* and Δ*ssa2* ([Fig. 5](#fig5){ref-type="fig"}). In cells with a single Hsp70 deletion, the remaining Hsp70s were present in the fibrillar core, the nonfibrillar perimeter shells, and the dark amorphous clumps ([Fig. 5 B](#fig5){ref-type="fig"}, yellow, red, and blue outlines, respectively). For the Δ*sse1* strain, only a modest (approximately twofold) increase in Hsp70 labeling was observed on the dot aggregates compared with the cytosol ([Fig. 5 D](#fig5){ref-type="fig"}). Again, the mesh-like amorphous material in these strains was poorly labeled with the α-Hsp70 antibody ([Fig. 5 C](#fig5){ref-type="fig"}, blue outline).

![**Immunogold detection of Hsp70 on NM-YFP assemblies in Hsp70 and Hsp110 knockout cell sections.** Same as for [Fig. 4](#fig4){ref-type="fig"}, but detection was with an α-Ssa antibody to label Hsp70. C, cytosol; D, dot aggregate; WT, wild type.](JCB_201505104_Fig5){#fig5}

Sse1 was not significantly concentrated in the dots in cells with a wild-type complement of chaperones ([Fig. 6 A](#fig6){ref-type="fig"}). In contrast, in Δ*ssa1* or Δ*ssa2* strains, there was a more than fourfold increase in the levels of Sse1 on the dot assemblies ([Fig. 6, B and D](#fig6){ref-type="fig"}). This redistribution of Sse1 was remarkable, given that Sse1 was not significantly up-regulated in these strains ([Fig. 3 A](#fig3){ref-type="fig"}). Furthermore, Sse1 was predominantly located in the nonfibrillar peripheral zones and the amorphous clumps with little fibril labeling ([Fig. 6 B](#fig6){ref-type="fig"}). As expected, barely detectable background labeling was observed with α-Sse1 labeling of sections from the Δ*sse1* strain, which was presumably attributable to Sse2, as described earlier ([Fig. 6, C and D](#fig6){ref-type="fig"}).

![**Immunogold detection of Sse1 on NM-YFP assemblies in Hsp70 and Hsp110 knockout cell sections.** Same as for [Fig. 4](#fig4){ref-type="fig"}, except that detection was with an α-Sse1 antibody. C, cytosol; D, dot aggregate; WT, wild type.](JCB_201505104_Fig6){#fig6}

Consistent with the fluorescence observations ([Fig. 3 B](#fig3){ref-type="fig"}), our Western blots revealed a low abundance of Hsp104 in NM-YFP--expressing cells with a wild-type chaperone complement ([Fig. 3 A](#fig3){ref-type="fig"}), making it undetectable by immunogold EM. For cell sections of the Hsp70 deletions (Δ*ssa1* and Δ*ssa2*), however, the elevated Hsp104 expression levels facilitated specific immunogold detection of Hsp104 (albeit with low labeling efficiency; [Fig. 7, A--D](#fig7){ref-type="fig"}), confirming the peripheral localization seen by confocal microscopy ([Fig. 3 C](#fig3){ref-type="fig"}).

![**Immunogold detection of Hsp104 on NM-YFP assemblies in Hsp70 knockout cell sections.** (A--D) Representative EM projection images of immunogold-labeled cell sections of Δ*ssa1* (A and B) and Δ*ssa2* (C and D) cells, as indicated. Detection was with an α-Hsp104 antibody. The red outlines, encompassing entire NM-YFP dot aggregates, were manually traced at the interface between the peripheral unstructured zone of the aggregates and the ribosomes in the cytosol.](JCB_201505104_Fig7){#fig7}

The perimeter shells thus contained Hsp70 (Ssa1/Ssa2; [Fig. 3 C](#fig3){ref-type="fig"} and [Fig. 5 B](#fig5){ref-type="fig"}), Hsp40/Sis1 ([Fig. 3 C](#fig3){ref-type="fig"}), and Hsp104 ([Fig. 3 C](#fig3){ref-type="fig"} and [Fig. 7, A--D](#fig7){ref-type="fig"}) and were significantly enriched for Hsp110/Sse1 (i.e., all of the major components of the yeast disaggregase machinery; [Fig. 6, B and D](#fig6){ref-type="fig"}). Therefore, these nonfibrillar zones define a region of NM-YFP aggregates with an altered balance between aggregation and disaggregation.

Hsp104 and Sse1 can independently influence NM-YFP fibril assembly {#s08}
------------------------------------------------------------------

Our immunogold labeling experiments suggested that NM-YFP fibrils are remodeled in regions enriched in Hsp104 and/or Sse1. To further test this hypothesis, we transiently overexpressed either Hsp104 or Sse1 individually (on plasmids pHsp104 or pSse1, respectively) in an otherwise wild-type chaperone background and examined the resulting NM-YFP dot assemblies by electron tomography.

In cells transiently overexpressing Hsp104, 80% of dot structures (40 dots examined) contained disorganized or amorphous regions ([Fig. 8, A and B](#fig8){ref-type="fig"}). The remaining dots contained large but normal NM-YFP fibrillar arrays (not shown). In the altered dot aggregates, large nonfibrillar zones were usually present, reminiscent of those seen in the Δ*ssa1* and Δ*ssa2* strains ([Fig. 1, B and C](#fig1){ref-type="fig"}; and [Fig. 8 A](#fig8){ref-type="fig"}). Both Hsp104 and Sse1 could be detected within the nonfibrillar zones in these dot aggregates ([Fig. 8, C and D](#fig8){ref-type="fig"}), consistent with their combined presence in these regions in the Δ*ssa1* and Δ*ssa2* strains. Other abnormal dot aggregates in this population comprised regions of highly fragmented and randomly arranged small fibrils that were often accompanied by dark-staining amorphous aggregates ([Fig. 8 B](#fig8){ref-type="fig"}).

![**Hsp104 overexpression disrupts NM-YFP aggregate organization.**(A and B) Representative tomographic slices from reconstructions of NM-YFP dots in cell sections of HM20-embedded cells with a wild-type chaperone complement and overexpressing Hsp104 from plasmid pHsp104. The interface between the cytosolic ribosomes and the aggregate surface was traced manually and outlined in red. Dark amorphous aggregates were manually outlined in blue. Bars, 200 nm. (C and D) Representative EM projection images of immunogold-labeled HM20-embedded cell sections of cells with a wild-type chaperone complement and overexpressing Hsp104. Sections were labeled with either α-Hsp104 (C) or α-Sse1 (D) antibodies, as indicated. The labeling shows the combined presence of Hsp104 and Sse1 in the unstructured perimeter zones. Fibril-containing regions were manually traced around the interface between the fibrils and the surrounding unstructured zone and are outlined in yellow. The unstructured material is outlined in red and was manually traced at the interface between the unstructured zone and the cytosolic ribosomes. Bars, 0.5 µm.](JCB_201505104_Fig8){#fig8}

Transient overexpression of Sse1 also resulted in a majority of abnormal NM-YFP aggregate assemblies. Here, ∼75% were disorganized, whereas the remaining assemblies were large but normal-looking dots. The disrupted dots had an extremely disordered fibrillar core surrounded by a web of darkly stained amorphous material ([Fig. 9, A and B](#fig9){ref-type="fig"}). This material did not contain NM-YFP ([Fig. 9, C and D](#fig9){ref-type="fig"}) and was reminiscent of the dark amorphous aggregates seen occasionally in fibril assemblies in the Δ*sse1* strain, as described earlier.

![**Sse1 overexpression disrupts NM-YFP aggregate organization.**(A and B) Representative tomographic slices from reconstructions of NM-YFP dots in cell sections of HM20-embedded cells with a wild-type chaperone complement and overexpressing Sse1 from plasmid pSse1. Normal fibrillar regions are outlined in yellow, manually traced at the interface between the fibrils and the surrounding cytosolic ribosomes and/or mesh-like amorphous aggregates. The mesh-like amorphous material was manually outlined in green. Bars, 200 nm. (C and D) Representative EM projection images of immunogold-labeled HM20-embedded cell sections of cells with a wild-type chaperone complement and overexpressing Sse1. Sections were labeled with an α-YFP antibody to detect NM-YFP. The mesh-like amorphous material was sparsely labeled, suggesting that it contained mostly other aggregates. Fibrils are outlined in yellow and the amorphous material is outline in green, as described for A and B. Bars, 0.5 µm.](JCB_201505104_Fig9){#fig9}

Discussion {#s09}
==========

We have explored the role of the Hsp70 chaperone system in the in situ organization of a \[*PSI*+\] prion model. We describe a novel nonfibrillar surface layer of amyloid-containing dot aggregates that appears to result from an altered balance between fibril assembly and disassembly. This material was indistinguishable from the "normal" fibrillar NM-YFP aggregates in our cells by fluorescence and could only be discerned by electron tomography.

We used a model system with a highly overexpressed but nontoxic form of the \[*PSI+*\] prion. This enabled us to visualize the 3D structure of the aggregates by correlative fluorescence and electron tomography and to probe the effects of modulating the major Hsp70-related chaperones. Although the fluorescent foci appear small and dispersed under native expression conditions ([@bib57]; [@bib64]; [@bib51]), it seems likely that similar molecular interactions would occur in the smaller aggregates.

Although yeast prion proteins can assemble into amyloid fibrils in vitro in the absence of additional cofactors, interactions with the protein quality control machinery are required for their assembly, deposition, and propagation in yeast cells ([@bib73]; [@bib40]; [@bib74]). Perturbing proteostasis through selective Hsp70 deletion revealed the nonfibrillar aggregates of NM-YFP, giving a nanoscale structural view of processes underlying previous observations of the cellular roles of Hsp70s on prion propagation ([@bib61]; [@bib62]). Our single Hsp70 deletions stably propagated dot aggregates of NM-YFP, but changes in expression level of the Hsp104 disaggregase appear to account for the observed dramatic structural changes. First, although the Δ*ssa1* and Δ*ssa2* strains maintained global Hsp70 and Sse1 expression levels, there was an up-regulation of Hsp104 ([Fig. 3 A](#fig3){ref-type="fig"}). Moreover, Hsp104 was primarily located around the periphery of NM-YFP dots ([Fig. 3, C--E](#fig3){ref-type="fig"}; and [Fig. 7](#fig7){ref-type="fig"}). In addition, there was a marked recruitment of Sse1 to this boundary region in Δ*ssa1* and Δ*ssa2* cells ([Fig. 6 B](#fig6){ref-type="fig"}). Our findings indicate that recruitment of Hsp104 and Hsp110/Sse1, rather than loss of a specific Hsp70 function, plays a key role in the structural changes, possibly by aggregate remodeling.

It is well established that Hsp104 is essential for \[*PSI*+\] propagation ([@bib13]), most likely by fibril trimming/fragmentation in cooperation with Hsp70/Hsp40, to generate new seeds ([@bib46]; [@bib21]; [@bib82]; [@bib28]; [@bib68]; [@bib69]; [@bib31]; [@bib47]; [@bib85]; [@bib51]). Although there is evidence that Hsp110/Sse1 is also involved in these processes, its precise role has been unclear. As a major nucleotide exchange factor for Hsp70, Sse1 can stimulate amyloid fragmentation by Hsp104 both in vivo and in vitro ([@bib19]; [@bib36]; [@bib55]; [@bib63]). Recent studies show that Sse1 (and Hsp110 in mammals), together with Hsp70/Hsp40, acts as a disaggregase ([@bib63]; [@bib53]; [@bib65]; [@bib70]), although the in vitro reaction with Sup35 NM fibrils was extremely slow ([@bib17]; [@bib70]).

What is the function of Sse1 in the nonfibrillar, peripheral regions of NM-YFP assemblies in our strains? This question was addressed by examining the morphology of dot aggregates generated in the absence of Sse1. Although deletion of *SSE1* causes slow growth in yeast ([@bib49]; [@bib71]; [@bib1]), our Δ*sse1* strain stably propagated NM-YFP dot aggregates. Interestingly, the fibrils within NM-YFP dots from Δ*sse1* cells were approximately 60% longer than those from Δ*ssa1*, Δ*ssa2*, and cells with a wild-type chaperone complement ([Fig. 1 E](#fig1){ref-type="fig"}). Unlike an Hsp104 knockout, which cannot propagate \[*PSI*+\] ([@bib13]), it would appear that removal of Sse1 alters the balance toward \[*PSI*+\] fibril growth over cleavage, resulting in aggregates with longer fibrils. By contrast, the Hsp70 deletions (Δ*ssa1* and Δ*ssa2*) did not affect the lengths of the remaining fibrils ([Fig. 1 E](#fig1){ref-type="fig"}), despite the elevated Hsp104 levels in these mutants. We hypothesize that in these strains, remodeling of the outer layer of the aggregates most likely results from elevated Hsp104 progressively disassembling fibrils in initially normal dots, starting from the outer surface.

The alterations in aggregate morphology suggest direct functional roles for both Hsp104 and Sse1 in fragmentation and disassembly of NM-YFP fibrils in vivo. But what are the individual contributions of these two molecular chaperones to this process? In our \[*PSI*+\] model, we found that transient overexpression of either Hsp104 or Sse1 separately had a significant effect on the resulting NM-YFP dot morphology. Hsp104 overexpression reproduced the nonfibrillar zones seen in aggregates in the Hsp70 deletions ([Fig. 8 A](#fig8){ref-type="fig"}) with Sse1 recruited to these amorphous regions ([Fig. 8 D](#fig8){ref-type="fig"}). Overexpression of Sse1 produced more disorganized NM-YFP dot assemblies, often surrounded by mesh-like, amorphous, unidentified aggregates ([Fig. 9, A and B](#fig9){ref-type="fig"}). The Hsp104 overexpression result supports the notion that it simply disassembles NM-YFP fibrils. This conclusion was originally based on the reduction in aggregate size observed by SDD-AGE, a method that does not distinguish between individual polymers and clumps ([@bib37]) Sse1, however, appears to regulate fibril length and organization in a more measured type of fragmentation.

In summary, our findings reveal the in situ roles of Hsp104 and Sse1 as principal determinants of the in situ amyloid structure. Our manipulations revealed an active zone in which these chaperones were enriched, likely remodeling the aggregate species found there. Deletion of *SSE1* did not result in a nonfibrillar zone despite the clear localization of Hsp104 to the dot periphery ([Fig. 3 E](#fig3){ref-type="fig"} and Fig. S4 C). It therefore seems that both chaperone components are required to efficiently process fibrils of NM-YFP. Notably, these structural changes did not affect prion stability, still generating prion seeds that maintain epigenetic inheritance. This work has allowed us, for the first time, to directly visualize products generated by the yeast disaggregation machinery in vivo. How reduced Ssa and/or elevated Hsp104 levels trigger the observed redistribution of Sse1 and whether or not there is a direct interaction between Hsp104 and Sse1 is unclear. In addition, the precise role played by Sse1 in disaggregation warrants further investigation. A thorough understanding of the interplay between Hsp110s, such as Sse1, and their partner chaperones in dealing with amyloid aggregates in cells could potentiate strategies for controlling protein conformational disorders.

Materials and methods {#s10}
=====================

Yeast strains media and plasmids {#s11}
--------------------------------

Yeast strains for the analysis of \[*PSI*+\] aggregates were derived from the 74D-694 background (MATα, *ade1-14 ura3-52 leu2-3,112 trp1-289 his3-*Δ*200*; [@bib13]), which was manipulated to constitutively propagate an NM-YFP fusion in the prion state ([@bib75]). The NM domain--encoding region of the endogenous *SUP35* gene was deleted in this parental strain and an NM-YFP fusion cassette, expressed from the constitutive GPD promoter, was integrated at the *TRP* locus. Strains were grown using standard culturing techniques in YPD media (1% yeast extract, 2% peptone, and 2% glucose) or synthetic dropout media (0.7% yeast nitrogen base without amino acids, 2% glucose) lacking the relevant nutrient for auxotrophic plasmid selection. Excess adenine, at 100 mg/l, was included in media when growing 74D-694 derivatives. Where appropriate, antibiotic selection was achieved using G418 (200 µg/ml) or hygromycin B (50 µg/ml).

Construction of the Δ*ssa1*, Δ*ssa2*, and Δ*sse1* deletion derivatives of our NM-YFP parental strain was achieved using a standard PCR-based deletion strategy ([@bib8]; [@bib79]). In brief, the *kanMX4* cassette from plasmid pDH6 (Yeast Resource Centre; [@bib80]) was amplified by PCR, incorporating the appropriate flanking homology sequences for targeted integration and gene deletion by homologous recombination, using the oligonucleotide combinations listed in [Table S1](http://www.jcb.org/cgi/content/full/jcb.201505104/DC1){#supp7}. Cells were transformed with these PCR products using a standard lithium acetate transformation protocol and were selected for resistance to G418. The integrity of the deletions was confirmed by colony PCR.

Fluorescent protein labeling of Hsp104, Ssa1, Ssa2, and Sis1 for colocalization studies with NM-YFP was conducted by a C-terminal fusion of the respective chromosomal coding sequence with mCherry ([@bib60]) using standard PCR targeting ([@bib80]). The integration cassettes were amplified from plasmid pBS35 (Yeast Resource Centre) and contained the mCherry chromosomal coding sequence, the hygromycin B resistance cassette, and the appropriate flanking homology sequences for targeted integration. The oligonucleotide primer pairs used are listed in Table S1. Cells were transformed with these PCR products using a standard lithium acetate transformation protocol and were selected for resistance to hygromycin B. Correct integration was confirmed by PCR and the resulting fusions were verified by sequencing.

Plasmids pHsp104 and pSse1 were constructed by PCR amplification of *HSP104* and *SSE1*, respectively, and digestion with BamHI-SalI followed by ligation to p425Gal1 ([@bib50]), which had been digested with the same restriction endonuclease pair. Oligonucleotide pairs used are listed in Table S1. Both plasmids were verified by sequencing. Galactose induction of the Gal1 promoter on p425Gal1 was conducted by growing cultures initially in SD media (lacking leucine) with 2% glucose to mid-late log phase. Cells were then pelleted by centrifugation (3400 rpm, 10 min), resuspended in media with 2% galactose, and grown for a further 6 h. Overexpression of Hsp104 and Sse1 was verified by Western blotting.

Fluorescence microscopy of yeast cells {#s12}
--------------------------------------

For routine live-cell imaging, yeast cells were mounted on polysine slides (VWR International LLC) with coverslips (0.13- to 0.16-mm thick) in growth media. Conventional epifluorescence images were acquired using an Axioscope A1 microscope (Carl Zeiss), equipped with an X-Cite Series 120Q lamp and an Orca R2 charge-coupled device (CCD) camera (Hamamatsu Photonics), using a 63× Plan-Apochromat oil immersion objective lens (NA1.4). Imaging was performed with 500/20-nm and 535/30-nm excitation and emission filters, respectively, for YFP and 546/12-nm and LP 590-nm excitation and emission filters, respectively, for mCherry. Image analysis and processing were performed using Axiovision (Carl Zeiss) and Fiji ([@bib58]).

For colocalization studies, cells were grown to mid-late log phase, fixed with 4% PFA (Electron Microscopy Sciences) in growth media, and immobilized on 1% agarose pads with Mowiol on glass slides with coverslips. Confocal Z-stacks were acquired using a Leica TCS SP5 microscope equipped with an HCX Plan-Apochromat lambda blue 63× oil UV objective lens (NA1.4). For detection of the YFP signal, the 514-nm laser line was used and emission was collected within a band pass range of 527--581 nm. Excitation of mCherry was with the 594-nm laser line and emission was collected at 613--716 nm. Clear spectral separation of YFP and mCherry signals was ensured by the confocal settings, and sequential scanning was used during acquisition to minimize fluorophore cross talk. The photomultiplier tube voltage for both YFP and mCherry signals was optimized for detection of the fluorescence in the dot aggregate assemblies. Image analysis and processing were performed using Fiji ([@bib58]).

FRAP analysis was performed on live cells grown to mid-late log phase using the Leica TCS SP5 microscope and objective lens described in the preceding paragraph. Cells were immobilized on 1% agarose pads in growth media on glass slides with coverslips and imaged immediately. A 0.35-µm^2^ region of interest, typically corresponding to between 5% and 10% of the total area of an NM-YFP dot, was bleached with five 0.147-s pulses using the 513-nm laser line at full power. Bleaching conditions typically resulted in 90% loss in fluorescence in the bleached area. Recovery from photobleaching was then monitored every 0.2 s for 10 s and then every 1 s for 30 s. Background noise and total fluorescence in the NM-YFP dot were also monitored during the time course and used for normalization. The data were normalized using the easyFRAP program to account for differences in the starting intensities and for acquisition photobleaching during the time course ([@bib54]). The data presented for each strain were the mean of at least seven independent dot aggregates. Error bars in the graph correspond to the SD in the data.

EM sample preparation {#s13}
---------------------

Yeast cells grown to mid-late log phase were pelleted by centrifugation (3,400 rpm, 10 min) and resuspended in growth medium to achieve 500- to 1000-fold concentration. Aliquots were immediately transferred a Leica type A aluminum specimen carrier (0.2-mm indentation), covered with the flat side of a type B specimen carrier, and high-pressure frozen using the EM HPM100 system (Leica). Cryofixed samples were then freeze substituted and embedded with Lowicryl HM20 (Agar Scientific) using an EM AFS2 device (Leica) according to a protocol adapted from [@bib26]. In brief, cells were freeze substituted in dry acetone containing 0.1% uranyl acetate and 1% methanol at −90°C for 16 h. Samples were then warmed to −50°C at 20°C/h and washed twice in 100% ethanol for 30 min, before five exchanges with 1-h incubations into increasing concentrations of HM20 (25%, 50%, 75%, 100%, and 100%). A further exchange into 100% HM20 was then performed and incubation was continued at −50°C for 18 h. After a fresh HM20 exchange and a second 18-h incubation, the HM20 was polymerized under UV light at −50°C for 48 h. The samples were then warmed to 20°C at 10°C/h and polymerization was continued under UV illumination for an additional 48 h.

HM20-embedded sample blocks were then sectioned at RT on an EM UC7 Ultramicrotome (Leica) using an Ultra 45° diamond knife (Diatome). For tilt-series acquisition, cell sections (200- to 250-nm thick) were cut and mounted on carbon-coated 200-mesh copper finder grids (Agar Scientific). After fluorescence imaging (see below), sections on grids were poststained with 2% uranyl acetate in 70% methanol for 5 min, followed by 3 min in lead citrate ([@bib77]), and were subsequently coated on both sides with protein A gold (Electron Microscopy Sciences). Cell sections (100-nm thick) were mounted on carbon-coated 300-mesh copper grids (Agar Scientific) for immunogold labeling experiments.

For cryotomography, yeast cells were cryofixed in growth media containing 20% high molecular mass dextran using the EM HPM100 with the copper tube system (Leica). 65- to 100-nm-thick cryo-sections were cut at −140°C using an EM UC7 Ultramicrotome equipped with an EM FC7 cryochamber using a cryo 25°C diamond knife (Diatome). Cryosection ribbons were mounted on custom-made C-flat carbon-coated 200-mesh Gilder finder grids (Protochips Inc.) that had been covered with a 5-nm continuous carbon layer and coated with protein A gold. Cryosections were stored under liquid nitrogen for future use.

Correlative cryo-fluorescence imaging {#s14}
-------------------------------------

HM20-embedded cell sections mounted on EM grids were visualized by wet mount as described elsewhere ([@bib39]). 0.2-µm Blue FluoSpheres (365/415; Life Technologies) were applied to grids as fluorescent fiducials for correlation with EM projection images. Fluorescence microscopy was performed using an Axioscope A1 microscope, equipped with an X-Cite Series 120Q lamp and an Orca R2 CCD camera, and using a 63× Plan-Apochromat oil immersion objective lens (NA1.4). YFP signal was monitored using 546/512-nm and LP 590-nm excitation and emission filters, respectively. Blue FluoSpheres were imaged using G 365-nm and 445/450-nm excitation and emission filters, respectively. Correlation between fluorescence and low magnification EM images of the same sample was performed using the "cpselect," "cp2tform," and "tformfwd" functions from the image processing toolbox in MATLAB (The MathWorks, Inc.). Affine transformations accounting for translation, rotation, and scaling differences between the two images were calculated using the coordinate positions of the blue FluoSpheres as control point pairs. The coordinate positions of NM-YFP dots on fluorescence images were then transformed onto the corresponding low-magnification EM projection images. This process was repeated for EM images of a magnification series up to that used for tilt-series acquisition.

Cryofluorescence imaging of vitreous cryosections was performed with the same microscope described above equipped with a cryostage (Linkam Scientific Instruments) operated at −195°C, using a 100× LD EC Epiplan-Neofluor objective lens (NA0.75). Correlation to NM-YFP dots in fluorescently mapped cryosections was performed in real time on the electron microscope using a software routine written in MATLAB and described elsewhere ([@bib76]). The four grid bar corners of a single EM grid square were used as landmarks for the registration of fluorescence images with a view of the same area on the electron microscope. The EM stage coordinates of these four known points were recorded by the software, which then calculated, by affine transformation, the stage coordinates corresponding to an NM-YFP dot location on the fluorescence image. The software was then used to set the EM stage to the location of the NM-YFP dot in the sample. This method had an expected accuracy of 0.5 µm ([@bib76]). NM-YFP dots typically occupied an area of 0.7--1.7 µm^2^ in cell sections, so the EM field of view of 5.3 µm^2^ used for tilt-series acquisition (see below) was chosen so as to always include the feature of interest. Precise correlation validation was subsequently performed using the MATLAB image processing toolbox, as outlined above for resin cell sections. The pattern of holes in the C-flat support film and autofluorescence from the cryosections (recorded using G 365-nm and 445/450-nm excitation and emission filters) facilitated accurate correlation.

Immunogold labeling of HM20-embedded cell sections {#s15}
--------------------------------------------------

100-nm cell sections mounted on carbon-coated 300-mesh copper grids were used for on-section gold labeling. Grids were initially floated section-side down on 30-µl droplets of blocking buffer (1% BSA in PBS with 0.01% Tween 20) for 5 min. They were then transferred onto 30-µl droplets of the appropriate primary antibody diluted in blocking buffer and incubated at RT for 60 min. The grids were washed by six 2-min exchanges onto 60-µl droplets of blocking buffer before being transferred to 30-µl droplets of Protein-A gold, diluted 1:10 with blocking buffer. Incubation was continued at RT for 30 min. The grids were then washed with three changes of blocking buffer and three changes of PBS, for 2 min each. Labeling on the sections was then fixed by floating on 30-µl droplets of 1% buffered glutaraldehyde for 5 min, followed by four 1-min washes in milliQ water. NM-YFP was labeled with a mouse monoclonal α-YFP antibody (Takara Bio Inc.) at a working concentration of 20 µg/ml. A rabbit polyclonal α-Hsp104 antibody (Abcam) was used for Hsp104 labeling at a concentration of 50 µg/ml. Hsp70 labeling was with a rabbit polyclonal α-Ssa1 antibody diluted 1:50 ([@bib85]). Sse1 was labeled with a rabbit polyclonal α-Sse1 antibody diluted 1:50.

EM data collection and processing {#s16}
---------------------------------

Grids mounted with HM20-embedded cell sections were placed into a Model 2040 dual-axis tomography holder (Fischione Instruments) and imaged using a Tecnai F20 microscope (FEI) operated at 200 kV with a 4k CCD camera (Ultrascan US4000; Gatan). Dual-axis tilt series were collected using SerialEM ([@bib43]) typically over a tilt range of ±60° with 2° increments at an unbinned pixel size of 0.585 nm. The nominal defocus was 0.5 µm. For reconstruction, tilt-series images were binned to a pixel size of 1.17 nm and dual-axis tomograms were generated using the IMOD package, version 4 ([@bib35]; [@bib42]). For plotting of individual fibril lengths in NM-YFP dots, fibrils were measured using the model tools of the 3dmod software package implemented in IMOD (version 4; [@bib35]). The data were analyzed using MATLAB.

Imaging of immunogold-labeled cell sections was conducted on Tecnai T10 and T12 microscopes (FEI), operated at full voltage, and equipped with 1K Multiscan CCD cameras (Gatan). Images were collected at various magnifications within a calibrated pixel size range of between 1.5 and 4.3 nm. Quantification of labeling was performed using Fiji ([@bib58]).

Vitrified cryosections were imaged using a Tecnai Polara microscope (FEI) operated at 300 kV with a 4K CCD camera (Ultrascan US4000; Gatan). Tilt series were collected using SerialEM ([@bib43]) over a tilt range of ±60° with 1.5° increments at nominal defoci of between 8.0 and 10.0 µm and an unbinned pixel size of 0.563 nm. Low-dose conditions were implemented to apply a total dose of 60 e/Å^2^ for each tilt series. Tomogram reconstructions were performed using IMOD (version 4; [@bib35]).

Yeast lysate preparation, Western blotting, and SDD-AGE {#s17}
-------------------------------------------------------

Yeast cells were grown in the appropriate growth media to mid-late log phase, pelleted (3400 rpm, 10 min), and resuspended in lysis buffer (10 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.5 mM EDTA) with protease inhibitors (P8215; Sigma-Aldrich). Resuspended cells were lysed by explosive decompression with two passages through a French Pressure Cell (Aminco; Thermo Fisher Scientific) operated at 10,000 pounds per square inch. The resulting crude lysates were centrifuged to remove unlysed cells and cellular debris (2,700 rpm, 10 min) and the clarified lysates were then stored at −80°C for future use.

SDS-PAGE and Western blots were performed using standard techniques. For Western analysis, 3 µg of each lysate was run on gels and equal loading was monitored with an α-glucose-6-phosphate dehydrogenase--HRP conjugate antibody (ab34601; Abcam). α-YFP (Takara Bio Inc.), α-Ssa1 ([@bib85]), and α-Sse1 antibodies were used at a dilution of 1:10,000. α-Hsp104 (Abcam) was used at a dilution of 1:5,000. Band intensities were quantified using Fiji ([@bib58]) and analyzed in MATLAB.

SDD-AGE analysis was performed as previously described ([@bib37]; [@bib24]). In brief, 40 µg of the lysates was incubated for 5 min at 37°C in 0.5 M Tris-acetate-EDTA, 2% SDS, 5% glycerol, and 0.05% bromophenol blue and subjected to electrophoresis in 1.5% agarose with 0.1% SDS, without heating the samples or the gel during running. Prion protein was detected by immunoblotting with α-YFP.

Sedimentation profiling of yeast lysates was performed by centrifuging 1 ml of each lysate, adjusted to 0.5 mg/ml in lysis buffer, at 65,000 rpm in a TLA110 fixed angle rotor for 50 min using a Beckman Optima TLX Preparative Ultracentrifuge. The supernatant fractions were collected and the pellets were then resuspended in 1 ml of lysis buffer. Fractions were separated by SDS-PAGE or SDD-AGE and analyzed by Western blotting.

Database depositions {#s18}
--------------------

Representative tomograms have been deposited in the Electron Microscopy Databank with accession codes EMD-3118 (Fig. S2 E), EMD-3119 (Fig. S1 C), and EMD-3124 ([Fig. 2 D](#fig2){ref-type="fig"}).

Online supplemental material {#s19}
----------------------------

Fig. S1 shows live-cell fluorescence/differential interference contrast microscopy and cryoelectron tomography of NM-YFP dot aggregates. The fluorescent dot aggregates are resolved as bundles of hexagonally packed fibril arrays by electron tomography of both freeze-substituted and vitreous cryosections. In Fig. S2, tomographic sections of dot aggregates in yeast strains Δ*ssa1*, Δ*ssa2*, and Δ*sse1* show marked structural changes. The fibril arrays are disrupted or absent in Δ*ssa1* and Δ*ssa2* strains, and dark, amorphous material is associated with the aggregates. These features are confirmed in tomograms of cryosections. In the Δ*sse1* strain, large aggregates with long fibrils are overlaid by a meshwork of amorphous material. Fig. S3 shows FRAP curves reporting on molecular mobility in NM-YFP dot aggregates. In all of the above strains, the prion protein is immobile, including the ones with nonfibrillar regions. Fig. S4 contains line traces of fluorescence images of dots in wild-type, Δ*ssa2*, and Δ*sse1* strains, showing that Hsp104 is located around the periphery of the dot aggregates. The oligonucleotides used in this study are listed in Table S1. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201505104/DC1>.
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